DEAN INOUYE: Open Payments
NPI 1902874605 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$147 in 5 payments from 4 companies in 2025. Trend: 2023 $52 · 2024 $289 · 2025 $147
Food & beverage: $147
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $65 |
| Otsuka America Pharmaceutical, Inc. | 1 | $32 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
Products named: UZEDY, ABILIFY ASIMTUFII, AUSTEDO XR, INGREZZA, CAPLYTA.
Industry payments across VA — which companies pay providers there.
